关注
Nafiseh Keshavarzian
Nafiseh Keshavarzian
Department of Medicine, Université de Montréal
在 umontreal.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Cytokine profile and disease severity in patients with COVID-19
A Ghazavi, A Ganji, N Keshavarzian, S Rabiemajd, G Mosayebi
Cytokine 137, 155323, 2021
2002021
Evaluation of Leishmanization Using Iranian Lizard Leishmania Mixed With CpG-ODN as a Candidate Vaccine Against Experimental Murine Leishmaniasis
N Keshavarzian, M Noroozbeygi, M Haji Molla Hoseini, F Yeganeh
Frontiers in Immunology 11, 1725, 2020
102020
Reduction of Inflammatory C3 and C4 Complement Proteins in Severe COVID-19 Patients
A Ghazavi, G Mosayebi, N Keshavarzian, S Rabiemajd, A Ganji
62020
Investigation of osteoblast-like cells cultured on nano-hydroxyapatite/chitosan based composite scaffold in the treatment of bone defects and limited mobility
A Emamgholi, M Rahimi, SJS Tabaei, T Ghorbani, SA Ziai, PB Milan, ...
Nanomedicine Journal 6 (3), 167-175, 2019
42019
Integration of phytotherapy and chemotherapy: Recent advances in anticancer molecular pathways
RH Bushehri, P Navabi, AM Saeedifar, N Keshavarzian, NH Rouzbahani, ...
Iranian Journal of Basic Medical Sciences 26 (9), 987, 2023
22023
Comparison of the long‐term and short‐term protection in mouse model of Leishmania major infection following vaccination with Live Iranian Lizard Leishmania mixed with chitin …
M Noroozbeygi, N Keshavarzian, M Haji Molla Hoseini, S Haghdoust, ...
Parasite Immunology 46 (1), e13018, 2024
12024
Expression and alteration value of long noncoding RNA AB073614 and FER1L4 in patients with acute myeloid leukemia (AML)
A Ganji, M Khosravi, G Mosayebi, M Gholami, A Ghazavi, N Keshavarzian, ...
Asian Pacific Journal of Cancer Prevention: APJCP 24 (7), 2271, 2023
12023
Evaluation of the long-term immune responses following leishmanization using a live-Lizard Leishmania mixed with chitin
F Yeganeh, M Noroozbeygi, N Keshavarzian, S Haghdoust, MHM Hoseini
Authorea Preprints, 2023
2023
Efficacy of Two Vaccine Platforms against SARS-CoV-2
G Mosayebi, N Keshavarzian, P Navabi, A Ganji
Vaccine Research 9 (2), 18-23, 2022
2022
The Assessment of Complement Proteins in Patients With Severe COVID-19
A Ghazavi, G Mosayebi, N Keshavarzian, S Rabiemajd, A Ganji
Int J Basic Sci Med 6 (4), 152-156, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–10